Delivery Order SPE2DB24D8002-SPE2DB25FJPDK
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xulane 150-35 mcg/day contraceptive patches (quantity 3). This firm fixed-price delivery order, valued at $1,419.61, was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The award represents an unrestricted procurement with no set-aside designation and reflects the DLA's ongoing pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $2,584.98 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is priced on a firm fixed-price basis with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. This delivery order carries no set-aside designation and represents a straightforward pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,683.80 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-unit quantity). The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents performance under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.42 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Xulane 150-35 microgram/day transdermal patches (3-count units). Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order reflects the rapid fulfillment requirements typical of pharmaceutical supply chains supporting U.S. Armed Forces medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,686.83, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, having been awarded a significant Indefinite...
- This federal contract award, valued at $1,658.88, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. Dakota Drug, Inc. has a proven track record as a key strategic supplier for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,116.14 firm fixed price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award is not set aside and has an ultimate completion date of May 21, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
- Dakota Drug, Inc., a self-certified small disadvantaged business and subchapter S corporation, has been awarded a $2,806.97 firm fixed price delivery order for XULANE 150-35 MCG/DAY transdermal contraceptive patches by the Defense Logistics Agency Troop Support Medical. Performance will take place in Minot, North Dakota with an expected completion date of October 25, 2023. No set-aside designation was applied to this order for contraceptive products placed against an existing DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,298.29, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. It is a firm fixed-price contract with a performance period extending to March 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a ceiling value of $2,147.04, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 14, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a...